Klarquist Sparkman works at the cutting edge of intellectual property to help our biotechnology clients protect their rights.  As patent counsel for the National Institutes of Health, the Centers for Disease Control and Prevention, and many biotechnology companies and universities worldwide, the Firm works with leading researchers in diverse fields of biotechnology. 

Most of the professionals in Klarquist Sparkman’s biotechnology group have doctoral degrees, and many have considerable post-doctoral training.  The Firm’s biotechnology professionals have expertise in fields such as cell biology, molecular biology, immunology, genetics, physiology, neurobiology, plant biology, structural biology, biochemistry, virology, and ophthalmology.

The Firm’s biotechnology patent work has included protecting inventions related to proteins, genetic sequences, pharmaceuticals, gene therapy techniques, diagnostics and treatments for many different diseases (including cancer, HIV, and Alzheimer’s), immunology and monoclonal antibodies, high-throughput genomic and proteomic techniques, bioinformatics, medical devices, biological applications of nanotechnology, and biological imaging techniques.

The professionals in the Firm’s biotechnology group offer a unique combination of scientific and clinical knowledge.

Attorney contacts for our Biotechnology group: William Noonan, M.D. or Tanya Harding, Ph.D.